A Study to Evaluate the Use of an Indwelling Catheter to Obtain Cerebrospinal Fluid (CSF) by Low-rate Continuous Sampling (MK-0000-211)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

11 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-03-31

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a study to evaluate the feasibility and tolerability of low-rate continuous Cerebrospinal Fluid (CSF) sampling and to estimate the number of participants who exhibit severe baseline instability of CSF amyloid beta isoform Aß40 concentrations in healthy participants.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study to Measure CSF Proteins in Elderly Healthy Volunteers and Volunteers With Mild Cognitive Impairment or Alzheimer's Disease

NCT01436188

Healthy Alzheimer Disease

COMPLETED EARLY_PHASE1

Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers

NCT01126567

Healthy

COMPLETED

Cerebro Spinal Fluid Collection (CSF)

NCT04844060

Alzheimer Disease Dementia With Lewy Bodies Frontotemporal Dementia +2 more

RECRUITING

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

NCT01348061

Alzheimer Disease Progressive Supranuclear Palsy

COMPLETED

CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

NCT03652181

CCM Cavernoma Cerebral Cavernous Malformation +4 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer's Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Continuous drip sampling

Sampling at \~0.6 cc / hour (\~1.2 cc / 2 hours, or lowest feasible rate given technical requirements and volume requirements for core analytes assays)

No interventions assigned to this group

Intermittent sampling

Sampling at 4 cc every 2 hours (+ 2 cc dead space clearance, total = 6 cc / 2 hours)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must be in good health
* Must have a body mass index greater than or equal to 18 kg/m\^2 and less than or equal to 30 kg/m\^2

Exclusion Criteria

* Is pregnant, nursing, or plans to become pregnant
* Has clinically significant cardiovascular, renal, hepatic, gastrointestinal (GI), neurological, endocrine, hematological, dermatological or metabolic disease, or clinically significant abnormalities, as determined by medical history, physical examination, electrocardiogram, vital signs, or laboratory tests
* Has a history of migraine headaches
* Has a history of recent lumbar CSF sampling within 3 weeks prior to screening, history of lumbar spine surgery, or chronic low back pain or injury
* Has an infection or inflammation of the skin in or in close proximity to the area of the lumbar puncture site
* Has a history of a seizure disorder
* Is noted to have papilledema or clinically significant focal neurological deficits at the screening physical examination, as well as abnormalities of CSF pressure on initial testing once access to the lumbar space is achieved
* Has absolute or relative anatomic abnormalities that would be a contraindication to lumbar puncture
* Is a heavy consumer of alcohol
* Has used nicotine in the past 6 months
* Has a history of a significant psychiatric disorder

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes